CIK: 0001082621 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 12, 2021
Total Value ($000): $1,706,340 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AAPL | APPLE INC | 1,883,445 | $266,507 | 15.6% | $126.45 | +13.8% | COM | 037833100 |
| RPRX | ROYALTY PHARMA PLC | 7,142,856 | $258,143 | 15.1% | $49.50 | -21.5% | SHS CLASS A | G7709Q104 |
| META | FACEBOOK INC | 713,073 | $242,010 | 14.2% | $287.16 | +24.6% | CL A | 30303M102 |
| LNWO | SCIENTIFIC GAMES CORP | 2,678,571 | $222,509 | 13.0% | $21.43 | +228.9% | COM | 80874P109 |
| GOOGL | ALPHABET INC | 61,070 | $163,272 | 9.6% | $135.05 | 0.0% | CAP STK CL A | 02079K305 |
| AFRM | AFFIRM HLDGS INC | 753,804 | $89,801 | 5.3% | $69.70 | +14.7% | COM CL A | 00827B106 |
| ABCL | ABCELLERA BIOLOGICS INC | 4,105,095 | $82,266 | 4.8% | $45.73 | -61.3% | COM | 00288U106 |
| QQQ | INVESCO QQQ TR | 101,448 | $36,314 | 2.1% | $220.86 | — | UNIT SER 1 | 46090E103 |
| RXRX | RECURSION PHARMACEUTICALS IN | 1,509,254 | $34,728 | 2.0% | $29.60 | -4.2% | CL A | 75629V104 |
| IVV | ISHARES TR | 65,342 | $28,151 | 1.6% | $181.43 | — | CORE S&P500 ETF | 464287200 |
| TXG | 10X GENOMICS INC | 186,143 | $27,099 | 1.6% | $176.99 | -3.0% | CL A COM | 88025U109 |
| SANA | SANA BIOTECHNOLOGY INC | 1,163,601 | $26,204 | 1.5% | $25.65 | -18.2% | COM | 799566104 |
| RVMD | REVOLUTION MEDICINES INC | 670,382 | $18,442 | 1.1% | $27.68 | +5.1% | COM | 76155X100 |
| RLAY | RELAY THERAPEUTICS INC | 541,124 | $17,062 | 1.0% | $38.13 | -11.7% | COM | 75943R102 |
| — | ROCKET LAB USA INC | 1,000,000 | $16,130 | 0.9% | $16.13 | — | COM | 773122106 |
| GLD | SPDR GOLD TR | 91,955 | $15,101 | 0.9% | $126.45 | — | GOLD SHS | 78463V107 |
| — | PRAXIS PRECISION MEDICINES I | 778,517 | $14,395 | 0.8% | $55.02 | — | COM | 74006W108 |
| PCT | PURECYCLE TECHNOLOGIES INC | 1,069,600 | $14,204 | 0.8% | $22.89 | -34.2% | COM | 74623V103 |
| TNYA | TENAYA THERAPEUTICS INC | 673,270 | $13,903 | 0.8% | $21.49 | 0.0% | COM | 87990A106 |
| — | GENERATION BIO CO | 510,354 | $12,795 | 0.7% | $21.21 | — | COM | 37148K100 |
| FULC | FULCRUM THERAPEUTICS INC | 410,714 | $11,586 | 0.7% | $11.06 | +71.3% | COM | 359616109 |
| — | KINNATE BIOPHARMA INC | 498,001 | $11,464 | 0.7% | $39.78 | — | COM | 49705R105 |
| — | MELI KASZEK PIONEER CORP | 1,000,000 | $11,050 | 0.6% | $11.05 | — | CLASS A ORD | G5S74L106 |
| PLRX | PLIANT THERAPEUTICS INC | 562,379 | $9,493 | 0.6% | $26.54 | -20.0% | COM | 729139105 |
| NRIX | NURIX THERAPEUTICS INC | 314,762 | $9,430 | 0.6% | $25.20 | +22.5% | COM | 67080M103 |
| TNGX | TANGO THERAPEUTICS INC | 708,385 | $9,159 | 0.5% | $11.99 | 0.0% | COM | 87583X109 |
| VEA | VANGUARD TAX-MANAGED INTL FD | 162,699 | $8,215 | 0.5% | $35.96 | — | FTSE DEV MKT ETF | 921943858 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 229,144 | $5,855 | 0.3% | $29.63 | 0.0% | COM | 69404D108 |
| — | SURROZEN INC | 826,852 | $5,854 | 0.3% | $7.08 | — | COM | 86889P109 |
| IJR | ISHARES TR | 49,559 | $5,411 | 0.3% | $70.20 | — | CORE S&P SCP ETF | 464287804 |
| — | FS DEVELOPMENT CORP II | 400,000 | $3,980 | 0.2% | $9.96 | — | COM CL A | 30318F100 |
| VWO | VANGUARD INTL EQUITY INDEX F | 73,804 | $3,691 | 0.2% | $46.05 | — | FTSE EMR MKT ETF | 922042858 |
| IJH | ISHARES TR | 12,683 | $3,337 | 0.2% | $125.72 | — | CORE S&P MCP ETF | 464287507 |
| — | DECIBEL THERAPEUTICS INC | 328,798 | $2,535 | 0.1% | $11.36 | — | COM | 24343R106 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $2,421 | 0.1% | $12.01 | — | COM | 55910K108 |
| DYN | DYNE THERAPEUTICS INC | 107,252 | $1,742 | 0.1% | $21.96 | -19.3% | COM | 26818M108 |
| — | GEMINI THERAPEUTICS INC | 250,000 | $1,010 | 0.1% | $13.55 | — | COM | 36870G105 |
| — | SERES THERAPEUTICS INC | 131,847 | $918 | 0.1% | $24.50 | — | COM | 81750R102 |
| SRZNW | SURROZEN INC | 108,333 | $124 | 0.0% | $1.14 | — | *W EXP 08/01/203 | 86889P117 |
| AMPL | AMPLITUDE CL A ORD (NMQ) | 540 | $29 | 0.0% | $54.38 | 0.0% | CLASS A ORD | 03213A104 |